Yes, methamphetamine is an amphetamine. It belongs to a broader class of stimulant drugs called amphetamines, all of which share a common chemical backbone derived from a parent compound called phenethylamine. Methamphetamine is essentially amphetamine with one small structural modification: an extra methyl group (a carbon and three hydrogen atoms) attached to the molecule. That single addition changes how the drug behaves in the body in ways that matter.
How the Two Are Related
Amphetamines are a family of stimulants named after their simplest member, amphetamine. The family includes several compounds, among them methamphetamine, MDMA, and various prescription medications. All of them stimulate the central nervous system and increase activity in the brain’s reward and alertness pathways.
Think of it like a family tree. Phenethylamine sits at the top as the broad chemical class. Amphetamine is one branch. Methamphetamine is a more potent offshoot of that same branch. Your body actually recognizes this relationship: when you metabolize methamphetamine, about 4 to 7 percent of it is converted into plain amphetamine before being cleared from your system.
What One Methyl Group Changes
The extra methyl group on methamphetamine makes the molecule more fat-soluble. Because the brain is largely made of fatty tissue and is protected by a selective barrier that favors fat-soluble substances, methamphetamine crosses into the brain more easily than regular amphetamine. This higher lipophilicity is the main reason methamphetamine hits harder and faster when the two drugs are taken the same way.
Methamphetamine also stays in the body significantly longer. Its half-life is roughly 12 hours, meaning it takes about half a day for your body to eliminate just half of a single dose. Standard amphetamine (the kind found in common ADHD medications) has a shorter half-life, typically around 9 to 11 hours depending on the formulation. That longer duration means methamphetamine’s stimulant effects, and the stress it places on the brain and cardiovascular system, persist for an extended period.
Do They Affect the Brain Differently?
Both drugs increase dopamine, the brain chemical tied to motivation, pleasure, and reward. Animal research has found that methamphetamine and amphetamine can produce similar dopamine increases in certain brain regions. In rat studies, the two drugs showed equivalent effects on dopamine levels in the striatum, a region involved in movement and reward. Interestingly, one set of findings showed that methamphetamine was actually less effective than amphetamine at releasing dopamine in the prefrontal cortex, the area responsible for decision-making and impulse control.
In human studies comparing intranasal doses of the two drugs, plasma concentrations of both peaked around 3 to 4 hours after administration. The subjective effects, meaning how “high” participants reported feeling, were broadly similar at equivalent doses. The practical difference comes down to that longer half-life and easier brain penetration, which together make methamphetamine more intense and longer-lasting in real-world use patterns.
Both Have Approved Medical Uses
This surprises many people, but pharmaceutical-grade methamphetamine is a legal, FDA-approved medication. Sold under the brand name Desoxyn, it is prescribed for ADHD in patients six years and older, with a typical daily dose range of 20 to 25 milligrams. Amphetamine-based medications like Adderall and Dexedrine are far more commonly prescribed for the same condition, but methamphetamine remains an option when other treatments haven’t worked.
Both substances are classified as Schedule II controlled substances by the Drug Enforcement Administration. Schedule II means a drug has a recognized medical use but carries a high potential for abuse and dependence. Other drugs in this category include methylphenidate (Ritalin) and certain opioid painkillers.
Why the Distinction Matters
When people refer to “meth” casually, they almost always mean illicit methamphetamine, which is manufactured in unregulated settings and used at doses far beyond anything prescribed medically. At those doses, methamphetamine’s ability to flood the brain with dopamine causes severe neurotoxicity over time, damaging the nerve endings that produce dopamine and serotonin. This kind of damage is less commonly associated with prescription amphetamine use at therapeutic doses.
The difference between the two drugs is real but often overstated in popular culture. They are close chemical relatives that act on the same brain systems. Methamphetamine is more potent drop for drop, lasts longer, and enters the brain more readily. But at the molecular level, it is unmistakably an amphetamine, just a structurally modified and more powerful version of one.